Dutra Alves N, Reigado G, Santos M, Caldeira I, Hernandes H, Freitas-Marchi B
Front Bioeng Biotechnol. 2025; 13:1527854.
PMID: 40013305
PMC: 11861087.
DOI: 10.3389/fbioe.2025.1527854.
Wang M, Wang J, Xu X, Li E, Xu P
Mater Today Bio. 2024; 29:101351.
PMID: 39649247
PMC: 11621797.
DOI: 10.1016/j.mtbio.2024.101351.
Khan M
Polymers (Basel). 2024; 16(18).
PMID: 39339093
PMC: 11435517.
DOI: 10.3390/polym16182629.
Wu K, Gao A, Giunta M, Tran S
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204112
PMC: 11357265.
DOI: 10.3390/ph17081007.
Yao Y, Holdcraft R, Hagness S, Booske J
PLoS One. 2024; 19(4):e0298866.
PMID: 38687720
PMC: 11060518.
DOI: 10.1371/journal.pone.0298866.
Non-viral Gene Therapy for Melanoma Using Lysenin from Eisenia Foetida.
Ren M, Yang L, He L, Wang J, Zhao W, Yang C
Adv Sci (Weinh). 2024; 11(17):e2306076.
PMID: 38445883
PMC: 11077637.
DOI: 10.1002/advs.202306076.
Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy.
Liu S, Yu C, Wei H
Mater Today Bio. 2023; 22:100750.
PMID: 37545568
PMC: 10400933.
DOI: 10.1016/j.mtbio.2023.100750.
Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress.
Sun Z, Huang J, Fishelson Z, Wang C, Zhang S
Biomedicines. 2023; 11(7).
PMID: 37509610
PMC: 10377493.
DOI: 10.3390/biomedicines11071971.
Clinical applications of gene therapy for rare diseases: A review.
Papaioannou I, Owen J, Yanez-Munoz R
Int J Exp Pathol. 2023; 104(4):154-176.
PMID: 37177842
PMC: 10349259.
DOI: 10.1111/iep.12478.
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.
Shtykalova S, Deviatkin D, Freund S, Egorova A, Kiselev A
Life (Basel). 2023; 13(4).
PMID: 37109432
PMC: 10142071.
DOI: 10.3390/life13040903.
Challenges of Gene Editing Therapies for Genodermatoses.
Brooks I, Sheriff A, Moran D, Wang J, Jackow J
Int J Mol Sci. 2023; 24(3).
PMID: 36768619
PMC: 9916788.
DOI: 10.3390/ijms24032298.
Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement.
Farheen J, Hosmane N, Zhao R, Zhao Q, Iqbal M, Kong X
Mater Today Bio. 2022; 16:100450.
PMID: 36267139
PMC: 9576993.
DOI: 10.1016/j.mtbio.2022.100450.
Application of Genetically Encoded Molecular Imaging Probes in Tumor Imaging.
Du M, Wang T, Yang Y, Zeng F, Li Y, Chen Z
Contrast Media Mol Imaging. 2022; 2022:5473244.
PMID: 36101803
PMC: 9440812.
DOI: 10.1155/2022/5473244.
Progress in Intradermal and Transdermal Gene Therapy with Microneedles.
Zhu T, Zhang W, Jiang P, Zhou S, Wang C, Qiu L
Pharm Res. 2022; 39(10):2475-2486.
PMID: 36008737
DOI: 10.1007/s11095-022-03376-x.
Non-coding RNA delivery for bone tissue engineering: Progress, challenges, and potential solutions.
Guan S, Zhang Z, Wu J
iScience. 2022; 25(8):104807.
PMID: 35992068
PMC: 9385673.
DOI: 10.1016/j.isci.2022.104807.
Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy.
Schmidt D, Ebrahimabadi S, Gomes K, de Moura Aguiar G, Tirapelle M, Silvestre R
Immunother Adv. 2022; 2(1):ltac003.
PMID: 35919494
PMC: 9327111.
DOI: 10.1093/immadv/ltac003.
Microfluidic-Based Cationic Cholesterol Lipid siRNA Delivery Nanosystem: Highly Efficient In Vitro Gene Silencing and the Intracellular Behavior.
Zhu Z, Zhang L, Sheng R, Chen J
Int J Mol Sci. 2022; 23(7).
PMID: 35409359
PMC: 8999516.
DOI: 10.3390/ijms23073999.
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.
Tang Y, Chen Y, Zhang Z, Tang B, Zhou Z, Chen H
Pharmaceutics. 2021; 13(12).
PMID: 34959397
PMC: 8708448.
DOI: 10.3390/pharmaceutics13122116.
Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy.
Qin B, Jiang M, Li X, Shi Y, Zhang J, Luo Z
J Nanobiotechnology. 2021; 19(1):427.
PMID: 34922537
PMC: 8684184.
DOI: 10.1186/s12951-021-01144-4.
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies.
Ramos R, Picanco-Castro V, Oliveira T, Mendrone Junior A, de Santis G, Bonamino M
Hematol Transfus Cell Ther. 2021; 43 Suppl 2:S46-S53.
PMID: 34794797
PMC: 8606694.
DOI: 10.1016/j.htct.2021.09.007.